Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Document › Details

Compugen Ltd.. (11/7/17). "Press Release: Compugen Reports Third Quarter 2017 Results". Holon.

	Organisation	Compugen Ltd. (Nasdaq: CGEN)
	Group	Compugen (Group)
	Product	COM902 (anti-TIGIT antibody) (Compugen)
	Person	Sekhri, Paul J. (eGenesis 201901– CEO before Lycera + Sanofi + Teva + TPG Biotech + Cerimon + Ariad + Sprout)
	Person 2	Cohen-Dayag, Anat (Compugen 201112 CEO)

Original document
accessed by [iito] on 2017-11-09

Record changed: 2023-06-05

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Compugen (Group)

[1] Selexis S.A.. (3/7/18). "Press Release: Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics". Geneva....
[2] Compugen Ltd.. (11/6/17). "Press Release: Compugen to Initiate Manufacturing of COM902, Its Lead antiTIGIT Monoclonal Antibody". Holon....
[3] Compugen Ltd.. (8/2/17). "Press Release: Compugen Welcomes Paul Sekhri as its New Chairman of the Board". Holon....
[4] Compugen Ltd.. (2/15/17). "Press Release: Compugen Reports Fourth Quarter and Calendar Year 2016 Results". Holon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)